Dr Benjamin Daniels
- PhD, Pharmacoepidemiology (University of New South Wales)
- MA, Sociology & Statistics (McGill University)
- BSc, Psychology (Drexel University)
I am a nationally and internationally recognised leader in research leveraging linked administrative health data to investigate cancer treatment, outcomes, and national cancer policies. I am currently a Senior Research Fellow and Cancer Institute NSW Early Career Fellow within the Medicines Intelligence Research Program (MedIntel) at the School of Population Health. My research focuses on biologic cancer therapies, multiple medicine use (polypharmacy), opioids, and the policies governing access to medicines. I apply population health science methods to inform clinical, policy, and patient decisions. I promote policy that supports the quality use of medicines and good practice in the access to and use of real-world data for research purposes.
- Publications
- Media
- Grants
- Awards
- Research Activities
- Engagement
- Teaching and Supervision
- UNSW Cancer Seed Grant (2023; $50,000), "Harnessing big data to improve access to care and outcomes in refugees and recent migrants diagnosed with cancer " (Associate Investigator)
- Cancer Institute NSW Early Career Fellowship (2022 - 2025; $345,000), "Leveraging big data for real-world evidence generation: Impact of multi-medicine use on bowel cancer treatment and survivorship outcomes"
- UNSW Cancer Seed Grant (2022; $50,000), "Understanding the impact of SARS-CoV-2 (COVID-19) on Australian cancer treatment"
- NHMRC Ideas Grant, "Disentangling the interrelationship between multimordibity, multimedicine use, and cardiovascular health" (Associate Investigator) (2021 - 2023; $480,000)
- NHMRC Post-graduate scholarship (2015-2018; $84,000)
- 2020 - UNSW Medicine Early Career Academic Network (ECAN) Best Paper Award - Public Health
My Research Supervision
Jun Ni Ho (PhD candidate) - 'Optimisation of Risk Management for Biologic Medicines in Australia'